WITHDRAWN: Development, Optimization and Evaluation of Solid Lipid Nanoparticles of Celecoxib.

Q2 Pharmacology, Toxicology and Pharmaceutics

Pharmaceutical nanotechnology Pub Date : 2024-05-15 DOI:10.2174/2211738511666230831143111

Madhu Verma, Manish Gautam, Arun Nanda, Iti Chauhan, Mohd Yasir, Alok Pratap Singh, Sagarika Majhi, Raj Kumari, Meenakshi Sharma

{"title":"WITHDRAWN: Development, Optimization and Evaluation of Solid Lipid Nanoparticles of Celecoxib.","authors":"Madhu Verma, Manish Gautam, Arun Nanda, Iti Chauhan, Mohd Yasir, Alok Pratap Singh, Sagarika Majhi, Raj Kumari, Meenakshi Sharma","doi":"10.2174/2211738511666230831143111","DOIUrl":null,"url":null,"abstract":"<p><p>The article has been withdrawn at the request of the authors of the journal Pharmaceutical Nanotechnology. Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused. The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/pages/editorial-policies-main Bentham Science Disclaimer: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.</p>","PeriodicalId":19774,"journal":{"name":"Pharmaceutical nanotechnology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical nanotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2211738511666230831143111","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}

引用次数: 0

Abstract

The article has been withdrawn at the request of the authors of the journal Pharmaceutical Nanotechnology. Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused. The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/pages/editorial-policies-main Bentham Science Disclaimer: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.

查看原文本刊更多论文

撤回：开发、优化和评估塞来昔布的固体脂质纳米颗粒。

应《制药纳米技术》期刊作者的要求，该文章已被撤回。Bentham Science》杂志对由此给读者带来的不便深表歉意。关于撤稿的 Bentham 编辑政策，请访问 https://benthamscience.com/pages/editorial-policies-main Bentham Science 免责声明：向本刊投稿的稿件尚未发表，也不会同时在其他地方投稿或发表，这是发表的条件之一。此外，任何已在其他地方发表的数据、插图、结构或表格都必须报告，并且必须获得复制的版权许可。严禁剽窃，一旦发现剽窃或捏造信息，作者同意出版商有权依法对作者采取适当措施。提交稿件即表示作者同意，如果文章被接受发表，其版权即转让给出版商。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pharmaceutical nanotechnology Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science

CiteScore

4.20

自引率

0.00%

发文量

期刊介绍： Pharmaceutical Nanotechnology publishes original manuscripts, full-length/mini reviews, thematic issues, rapid technical notes and commentaries that provide insights into the synthesis, characterisation and pharmaceutical (or diagnostic) application of materials at the nanoscale. The nanoscale is defined as a size range of below 1 µm. Scientific findings related to micro and macro systems with functionality residing within features defined at the nanoscale are also within the scope of the journal. Manuscripts detailing the synthesis, exhaustive characterisation, biological evaluation, clinical testing and/ or toxicological assessment of nanomaterials are of particular interest to the journal’s readership. Articles should be self contained, centred around a well founded hypothesis and should aim to showcase the pharmaceutical/ diagnostic implications of the nanotechnology approach. Manuscripts should aim, wherever possible, to demonstrate the in vivo impact of any nanotechnological intervention. As reducing a material to the nanoscale is capable of fundamentally altering the material’s properties, the journal’s readership is particularly interested in new characterisation techniques and the advanced properties that originate from this size reduction. Both bottom up and top down approaches to the realisation of nanomaterials lie within the scope of the journal.